Vital Chemtech Limited has informed the Exchange about Approval received from NSE for Listing of its Equity shares on Capital Market Segment (Main Board) pursuant to Migration from SME Emerge platform with effect from March 11, 2026.
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vital Chemtech Limited (Symbol: VITAL, ISIN: INE0L4K01016) has received final listing approval from NSE to migrate its equity shares from the SME EMERGE platform to the Main Board (Capital Market Segment). Trading on the Main Board will commence from March 11, 2026. The company has 23,951,100 equity shares of face value Rs. 10 each fully paid up, with no lock-in restrictions. This is a regulatory milestone for the company, originally listed on the SME platform in November 2022 per NSE circular ref. NSE/CML/54385.
Main Board migration typically increases visibility, attracts a broader set of institutional investors, and may improve liquidity in the stock. For existing shareholders, this is a positive event signalling the company's growth and compliance track record since its SME listing.